Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1

Status

Recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 150Leukemia 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Leukemia, Myelomonocytic, Acute 26Leukemia, Monocytic, Acute 26Myelodysplastic Syndromes 24Leukemia, Erythroblastic, Acute 23Leukemia, Megakaryoblastic, Acute 22Congenital Abnormalities 21Leukemia, Promyelocytic, Acute 13Leukemia, Myelomonocytic, Chronic 12Anemia, Refractory, with Excess of Blasts 12Recurrence 8Myeloproliferative Disorders 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Lymphoma 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Eosinophilic, Acute 7Leukemia, Biphenotypic, Acute 7Leukemia, Basophilic, Acute 6Carcinoma, Hepatocellular 6Blast Crisis 6Neoplasm, Residual 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Neutropenia 3Neoplasms, Plasma Cell 3Lymphoma, Large-Cell, Immunoblastic 3

Interventions

Cyclophosphamide 22blinatumomab 18Cytarabine 15fludarabine 13Azacitidine 12venetoclax 10fludarabine phosphate 10Rituximab 8Lenalidomide 7Dexamethasone 7Methotrexate 6Daunorubicin 6Mercaptopurine 5daratumumab 4Whole-Body Irradiation 4Vincristine 4Melphalan 4Idarubicin 4Etoposide 4Busulfan 4pembrolizumab 3obinutuzumab 3Radiotherapy 3Maintenance 3Immunotherapy, Adoptive 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Drug Therapy 3Cladribine 3Asparaginase 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Neoplasm, Residual × Idarubicin × Clear all
NCT07059975 2025-11-04

UPDATE AML: UPdated Disease Monitoring And Treatment for Enhanced Outcomes for Pediatric AML

Baylor College of Medicine

Phase EARLY_PHASE1 Recruiting
36 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT07131059 2025-08-20

MRD-positive AML Clinical Study

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Recruiting
120 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT00198991 2022-08-18

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Goethe University

Phase 4 Completed
1,883 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03760445 2020-01-09

HDM201 Added to CT in R/R or Newly Diagnosed AML

Novartis

Phase 1/2 Withdrawn
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡